AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria

MB Axelsen; H Bliddal; LTH Jacobssen; MS Hansen; A Dudek; M Rell-bakalarska; M Boesen; J Stefanek; B Sundman-Engberg; M Østergaard

doi:10.1136/annrheumdis-2017-eular.1946

AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria

MB Axelsen, H Bliddal, LTH Jacobssen, MS Hansen, A Dudek, M Rell-bakalarska, M Boesen, J Stefanek, B Sundman-Engberg, M Østergaard

Department of Clinical Medicine

Original language	English
Article number	518
Journal	Annals of the Rheumatic Diseases
Volume	76
Issue number	Suppl 2
Pages (from-to)	1419
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2017-eular.1946
Publication status	Published - 2017

Access to Document

10.1136/annrheumdis-2017-eular.1946

1419.1.full.pdfFinal published version, 67.7 KB

http://ard.bmj.com/content/76/Suppl_2/1419.1

Cite this

Axelsen, MB., Bliddal, H., Jacobssen, LTH., Hansen, MS., Dudek, A., Rell-bakalarska, M., Boesen, M., Stefanek, J., Sundman-Engberg, B., & Østergaard, M. (2017). AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria. Annals of the Rheumatic Diseases, 76(Suppl 2), 1419. [518]. https://doi.org/10.1136/annrheumdis-2017-eular.1946

AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria. / Axelsen, MB; Bliddal, H; Jacobssen, LTH et al.

In: Annals of the Rheumatic Diseases, Vol. 76, No. Suppl 2, 518, 2017, p. 1419.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Axelsen, MB, Bliddal, H, Jacobssen, LTH, Hansen, MS, Dudek, A, Rell-bakalarska, M, Boesen, M, Stefanek, J, Sundman-Engberg, B & Østergaard, M 2017, 'AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria', Annals of the Rheumatic Diseases, vol. 76, no. Suppl 2, 518, pp. 1419. https://doi.org/10.1136/annrheumdis-2017-eular.1946

@article{8f825301d9634e2ea6b196964f9023bc,

title = "AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria",

author = "MB Axelsen and H Bliddal and LTH Jacobssen and MS Hansen and A Dudek and M Rell-bakalarska and M Boesen and J Stefanek and B Sundman-Engberg and M {\O}stergaard",

year = "2017",

doi = "10.1136/annrheumdis-2017-eular.1946",

language = "English",

volume = "76",

pages = "1419",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria

AU - Axelsen, MB

AU - Bliddal, H

AU - Jacobssen, LTH

AU - Hansen, MS

AU - Dudek, A

AU - Rell-bakalarska, M

AU - Boesen, M

AU - Stefanek, J

AU - Sundman-Engberg, B

AU - Østergaard, M

PY - 2017

Y1 - 2017

U2 - 10.1136/annrheumdis-2017-eular.1946

DO - 10.1136/annrheumdis-2017-eular.1946

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 1419

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

M1 - 518

ER -